Cargando…

Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation

Introduction. The aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma (GBM) patients following radiotherapy/temozolomide (RT/TMZ) by comparing Macdonald criterial to Response Assessment in Neuro-Oncology (RANO) criteria. The impact on prognosis and survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linhares, Paulo, Carvalho, Bruno, Figueiredo, Rita, Reis, Rui M., Vaz, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755387/ https://www.ncbi.nlm.nih.gov/pubmed/24000284 http://dx.doi.org/10.1155/2013/690585

Ejemplares similares

Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2023)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

The LUMIERE dataset: Longitudinal Glioblastoma MRI with expert RANO evaluation
por: Suter, Yannick, et al.
Publicado: (2022)

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2022)

Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?
por: Linhares, Paulo, et al.
Publicado: (2020)

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy
por: Chen, Xin, et al.
Publicado: (2021)

Glioblastoma in the elderly: Therapeutic dilemmas
por: Pereira, André F., et al.
Publicado: (2015)

Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
por: Kinger, Nikhar, et al.
Publicado: (2019)

CLRM-07 RANO 2.0: PROPOSAL FOR AN UPDATE TO THE RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR HIGH- AND LOW-GRADE GLIOMAS IN ADULTS
por: Wen, Patrick, et al.
Publicado: (2023)

Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial
por: Liu, Zhi-Cheng, et al.
Publicado: (2017)

Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study
por: Bjorland, Line Sagerup, et al.
Publicado: (2023)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
por: Xi, Jing, et al.
Publicado: (2021)

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma
por: Takigawa, Kosuke, et al.
Publicado: (2021)

Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
por: El-Abtah, Mohamed E, et al.
Publicado: (2022)

Long-Term Mortality Analysis in Parkinson's Disease Treated with Deep Brain Stimulation
por: Rocha, Sofia, et al.
Publicado: (2014)

A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression
por: Zhang, Peng, et al.
Publicado: (2015)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?
por: Imber, Brandon S, et al.
Publicado: (2019)

High levels of cellular proliferation predict pseudoprogression in glioblastoma patients
por: POULEAU, HENRI-BENJAMIN, et al.
Publicado: (2011)

Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
por: Sidibe, Ingrid, et al.
Publicado: (2022)

Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
por: McKenney, Anna Sophia, et al.
Publicado: (2022)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma
por: Leone, Riccardo, et al.
Publicado: (2023)

Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
por: Jang, Bum-Sup, et al.
Publicado: (2018)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
por: de Godoy, Laiz Laura, et al.
Publicado: (2023)

Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences
por: Wang, Wesley, et al.
Publicado: (2023)

Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria
por: Douri, Keiss, et al.
Publicado: (2023)

The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
por: Carvalho, Bruno, et al.
Publicado: (2021)

MLTI-13. RESPONSE ASSESSMENT OF MELANOMA BRAIN METASTASES TREATED BY STEREOTACTIC RADIOTHERAPY OR IMMUNOTHERAPY OR BOTH: A COMPARISON OF RECIST 1.1, RANO AND iRANO CRITERIA
por: Le Rhun, Emilie, et al.
Publicado: (2019)

Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer
por: Creavin, B, et al.
Publicado: (2017)

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
por: Hu, Leland S., et al.
Publicado: (2012)

Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas
por: Raman, Fabio, et al.
Publicado: (2023)

Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
por: Linhares, Paulo, et al.
Publicado: (2013)

Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
por: Reimer, Caroline, et al.
Publicado: (2017)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

New Onset Diplopia in Patients with Nasopharyngeal Carcinoma following Concurrent Chemoradiotherapy: Clinical Features and Etiology
por: Kau, Hui-Chuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hccprla9p1559ul23t33fj9h20